Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biosynthesis of catalytically active rat testosterone 5 alpha-reductase in microinjected Xenopus oocytes: evidence for tissue-specific differences in translatable mRNA.
???displayArticle.abstract???
The enzyme 4-ene-3-ketosteroid-5 alpha-oxidoreductase [5 alpha-reductase; 3-oxo-5 alpha-steroid delta 4-dehydrogenase, 3-oxo-5 alpha-steroid: (acceptor) delta 4-oxidoreductase, EC 1.3.99.5] plays a key role in androgen-dependent target tissues, where it catalyzes the conversion of testosterone to the biologically active dihydrotestosterone. The regulation of 5 alpha-reductase expression has not been studied at the molecular level as the enzyme is a membrane protein that is labile in cell-free homogenates. We developed a sensitive bioassay of the enzyme activity expressed in Xenopus oocytes microinjected with rat liver and prostate mRNA. After microinjection, incubation of intact oocytes in the presence of [3H]testosterone revealed the in ovo appearance of active 5 alpha-reductase. Polyadenylated RNA was fractionated by sucrose gradient centrifugation, and the enzymatic activity was shown to be encoded by a 1600- to 2000-base-pair fraction of hepatic poly(A)+ RNA. 5 alpha-Reductase mRNA was most efficiently translated when up to 80 ng of RNA was injected per oocyte. In the injected oocytes, 5 alpha-reductase mRNA was found to be a short-lived molecule (t1/2 = 2 hr), whereas its in ovo translatable 5 alpha-reductase protein exhibited stable enzymatic activity for over 40 hr. Moreover, the levels of translatable tissue-specific 5 alpha-reductase mRNAs as monitored in the Xenopus oocytes correlated with the variable 5 alpha-reductase activities in female rat liver, male rat liver, and prostate homogenates; the ratio of their specific activities was of 2500:630:1, respectively. Altogether, these results provide supporting evidence in favor of the transcriptional control of 5 alpha-reductase expression in rat tissues.
Anderson,
Selective retention of dihydrotestosterone by prostatic nuclei.
1968, Pubmed
Anderson,
Selective retention of dihydrotestosterone by prostatic nuclei.
1968,
Pubmed
Baulieu,
Metabolism of testosterone and action of metabolites on prostate glands grown in organ culture.
1968,
Pubmed
Bertics,
Pituitary progesterone 5 alpha-reductase: solubilization and partial characterization.
1985,
Pubmed
Bingham,
The metabolism of testosterone by human male scalp skin.
1973,
Pubmed
Bruchovsky,
The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.
1968,
Pubmed
Burmeister,
Production of EGF-containing polypeptides in Xenopus oocytes microinjected with submaxillary gland mRNA.
1984,
Pubmed
,
Xenbase
Campbell,
The kinetic mechanism of the anterior pituitary progesterone 5 alpha-reductase.
1986,
Pubmed
Denef,
Sex-dependent changes in pituitary 5alpha-dihydrotestosterone and 3alpha-androstanediol formation during postnatal development and puberty in the rat.
1974,
Pubmed
Geller,
Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate.
1976,
Pubmed
Giorgi,
The transport of steroids into animal cells in culture.
1981,
Pubmed
Giorgi,
The transport of steroid hormones into animal cells.
1980,
Pubmed
Goldring,
Concerted metabolism of steroid hormones produced by cocultured ovarian cell types.
1985,
Pubmed
Gurdon,
Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells.
1971,
Pubmed
,
Xenbase
Gustafsson,
Properties of nuclear 5 alpha-reductase in rat liver.
1974,
Pubmed
Hanukoglu,
Progesterone metabolism in the pineal, brain stem, thalamus and corpus callosum of the female rat.
1977,
Pubmed
Imperato-McGinley,
Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency--a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity.
1979,
Pubmed
Kuttenn,
Androgen production and skin metabolism in hirsutism.
1977,
Pubmed
Liang,
Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.
1983,
Pubmed
MacIndoe,
Steroid-metabolizing enzymes in human breast cancer cells. II. 5 alpha-Reductase, 3 alpha-hydroxysteroid oxidoreductase, and 17 beta-hydroxysteroid oxidoreductase.
1981,
Pubmed
Martini,
The 5alpha-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications.
1982,
Pubmed
Massa,
Conversion of testerone into 5alpha-reduced metabolites in the anterior pituitary and in the brain of maturing rats.
1975,
Pubmed
Masu,
cDNA cloning of bovine substance-K receptor through oocyte expression system.
,
Pubmed
,
Xenbase
Meikle,
Supranormal nuclear content of 5 alpha-dihydrotestosterone in benign hyperplastic prostate of humans.
1980,
Pubmed
Miskin,
Microinjected Xenopus oocytes synthesize active human plasminogen activator.
1981,
Pubmed
,
Xenbase
Moore,
Extraction of the reduced nicotinamide adenine dinucleotide phosphate:delta 4-3-ketosteroid-5-alpha oxidoreductase of rat prostate with digitonin and potassium chloride.
1974,
Pubmed
Prody,
Use of synthetic oligodeoxynucleotide probes for the isolation of a human cholinesterase cDNA clone.
1986,
Pubmed
Sansone,
Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin--a possible pathogenic factor in acne.
1971,
Pubmed
Scheer,
Solubilization and partial characterization of rat epididymal delta 4-steroid 5 alpha-reductase (cholestenone 5 alpha-reductase).
1983,
Pubmed
Schmidt,
Metabolism and mode of action of androgens in target tissues of male rats. II. Mode of action of testosterone and 5 -dihydrotestosterone at a cellular level on seminal vesicles and prostates of rats.
1972,
Pubmed
Soreq,
Biosynthesis and secretion of catalytically active acetylcholinesterase in Xenopus oocytes microinjected with mRNA from rat brain and from Torpedo electric organ.
1982,
Pubmed
,
Xenbase
Soreq,
The biosynthesis of biologically active proteins in mRNA-microinjected Xenopus oocytes.
1985,
Pubmed
,
Xenbase
Soreq,
Expression of cholinesterase gene(s) in human brain tissues: translational evidence for multiple mRNA species.
1984,
Pubmed
,
Xenbase
Verhoeven,
Interconversion between 17 beta-hydroxy-5alpha-androstan-3-one (5alpha-dihydrotestosterone) and 5alpha-androstane-3alpha, 17 beta-diol in rat kidney: heterogeneity of 3alpha-hydroxysteroid oxidoreductases.
1976,
Pubmed
Wilson,
The pathogenesis of benign prostatic hyperplasia.
1980,
Pubmed
Wilson,
The mechanism of phenotypic sex differentiation.
1979,
Pubmed
YATES,
Sex difference in rate of ring A reduction of delta 4-3-keto-steroids in vitro by rat liver.
1958,
Pubmed
